124 related articles for article (PubMed ID: 10657546)
1. Changes in hypothalamic paraventricular nucleus catecholaminergic activity after acute and chronic morphine administration.
Fuertes G; Milanés MV; Rodríguez-Gago M; Marín MT; Laorden ML
Eur J Pharmacol; 2000 Jan; 388(1):49-56. PubMed ID: 10657546
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
Fuertes G; Laorden ML; Milanés MV
Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of protein kinase C but not protein kinase A attenuates morphine withdrawal excitation of rat hypothalamus-pituitary-adrenal axis.
Cerezo M; Laorden ML; Milanés MV
Eur J Pharmacol; 2002 Sep; 452(1):57-66. PubMed ID: 12323385
[TBL] [Abstract][Full Text] [Related]
4. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
Laorden ML; Fuertes G; González-Cuello A; Milanés MV
J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
[TBL] [Abstract][Full Text] [Related]
5. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response.
Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):603-10. PubMed ID: 9402040
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of corticotropin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: an in situ hybridization study.
Laorden ML; Milanés MV; Angel E; Tankosic P; Burlet A
J Neuroendocrinol; 2003 Jun; 15(6):586-91. PubMed ID: 12716409
[TBL] [Abstract][Full Text] [Related]
8. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
Benavides M; Laorden ML; Milanés MV
J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
[TBL] [Abstract][Full Text] [Related]
9. Effects of morphine and U-50,488H on neurochemical activity of the hypothalamic noradrenergic neurons and pituitary-adrenal response.
Laorden ML; Milanés MV
Neuropeptides; 1999 Apr; 33(2):131-5. PubMed ID: 10657482
[TBL] [Abstract][Full Text] [Related]
10. Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus.
Laorden ML; Milanés MV
Life Sci; 2000 Jan; 66(9):803-15. PubMed ID: 10698355
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous changes in hypothalamic catecholamine levels and plasma corticosterone concentration in the rat after acute morphine and during tolerance.
Milanés MV; Puig MM; Vargas ML
Neuropeptides; 1993 May; 24(5):279-84. PubMed ID: 8327071
[TBL] [Abstract][Full Text] [Related]
12. CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.
Navarro-Zaragoza J; Núñez C; Ruiz-Medina J; Laorden ML; Valverde O; Milanés MV
Br J Pharmacol; 2011 Feb; 162(4):851-62. PubMed ID: 20973778
[TBL] [Abstract][Full Text] [Related]
13. Catecholaminergic activity and 3',5'-cyclic adenosine monophosphate concentrations in the right ventricle after acute and chronic morphine administration in the rat.
Milanés MV; Fuente T; Marín MT; Laorden ML
Br J Anaesth; 1999 Nov; 83(5):784-8. PubMed ID: 10690144
[TBL] [Abstract][Full Text] [Related]
14. Involvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawal.
Martín F; Núñez C; Marín MT; Laorden ML; Kovács KJ; Milanés MV
PLoS One; 2012; 7(2):e31119. PubMed ID: 22355339
[TBL] [Abstract][Full Text] [Related]
15. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus.
Núñez C; González-Cuello A; Sánchez L; Vargas ML; Milanés MV; Laorden ML
Eur J Pharmacol; 2009 Oct; 620(1-3):1-8. PubMed ID: 19683523
[TBL] [Abstract][Full Text] [Related]
16. Modulation by catecholamine of hypothalamus-pituitary-adrenocortical (HPA) axis activity in morphine-tolerance and withdrawal.
Martinez-Piñero MG; Milanes MV; Vargas ML
Gen Pharmacol; 1994 Jan; 25(1):187-92. PubMed ID: 8026704
[TBL] [Abstract][Full Text] [Related]
17. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response.
Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
J Pharmacol Exp Ther; 1998 May; 285(2):700-6. PubMed ID: 9580616
[TBL] [Abstract][Full Text] [Related]
18. The sigma ligand rimcazole activates noradrenergic neurons projecting to the paraventricular nucleus and increases corticosterone secretion in rats.
Eaton MJ; Lookingland KJ; Moore KE
Brain Res; 1996 Sep; 733(2):162-6. PubMed ID: 8891298
[TBL] [Abstract][Full Text] [Related]
19. Effects of U-50488H and U-50488H withdrawal on c-fos expression in the rat paraventricular nucleus. Correlation with c-fos in brainstem catecholaminergic neurons.
Laorden ML; Castells MT; Milanés MV
Br J Pharmacol; 2003 Apr; 138(8):1544-52. PubMed ID: 12721110
[TBL] [Abstract][Full Text] [Related]
20. Transgenerational blunting of morphine-induced corticosterone secretion is associated with dysregulated gene expression in male offspring.
Vassoler FM; Toorie AM; Byrnes EM
Brain Res; 2018 Jan; 1679():19-25. PubMed ID: 29129606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
